McKesson (MCK) return on equity (ROE)

Return on equity · fiscal 2020
17.7%

McKesson (MCK) earned a return on equity of 17.7% in fiscal 2020 (the year ended March 31, 2020). That is 17.3 percentage points higher than the 0.4% of fiscal 2019. Figures as of 18 Nov 2026, 01:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2020
17.7%
Change on fiscal 2019
+17.3 pts
Highest on record
45.7%fiscal 2017
Lowest on record
0.4%fiscal 2019
Fiscal years on record
122009–2020

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

McKesson return on equity (ROE), in more detail

Across the 12 fiscal years on record (2009–2020), the highest was 45.7% in fiscal 2017 and the lowest 0.4% in fiscal 2019. The fiscal 2020 figure is higher than in 55% of the 11 earlier fiscal years on record, whose median is 16.8%.

History · 12 fiscal years

Return on equity by fiscal year

McKesson return on equity (ROE), year by year

McKesson (MCK) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202017.7% 17.3 pts up
20190.4% 0.3 pts down
20180.7% 45.0 pts down
201745.7% 20.4 pts up
201625.3% 6.9 pts up
201518.4% 3.6 pts up
201414.8% 4.1 pts down
201318.9% 1.6 pts down
201220.5% 3.9 pts up
201116.6% 0.1 pts down
201016.8% 3.5 pts up
200913.3%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of McKesson and comparable companies
CompanyReturn on equityFiscal year
Medtronic MDT9.7%2026
Bristol-Myers Squibb BMY38.2%2025
Stryker SYK14.5%2025
McKesson MCK17.7%2020
Sanofi SNY10.9%2025
Moderna MRNA-32.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MCK

McKesson, figure by figure

McKesson (MCK) overview: price, valuation and scorecardAll health care companies by market value

McKesson return on equity (ROE): questions and answers

What is McKesson's return on equity?

McKesson (MCK) earned a return on equity of 17.7% in fiscal 2020 (the year ended March 31, 2020). That is 17.3 percentage points higher than the 0.4% of fiscal 2019.

Is McKesson's return on equity high or low compared with its own history?

The fiscal 2020 figure is higher than in 55% of the 11 earlier fiscal years on record, whose median is 16.8%.

What are the highest and lowest return on equity figures on record for McKesson?

Across the 12 fiscal years on record (2009–2020), the highest was 45.7% in fiscal 2017 and the lowest 0.4% in fiscal 2019.

How is McKesson's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “McKesson (MCK) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/MCK/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.